DL Longo

5.7k total citations
83 papers, 4.8k citations indexed

About

DL Longo is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, DL Longo has authored 83 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Immunology, 26 papers in Oncology and 19 papers in Molecular Biology. Recurrent topics in DL Longo's work include Immune Cell Function and Interaction (27 papers), Chronic Lymphocytic Leukemia Research (15 papers) and Lymphoma Diagnosis and Treatment (14 papers). DL Longo is often cited by papers focused on Immune Cell Function and Interaction (27 papers), Chronic Lymphocytic Leukemia Research (15 papers) and Lymphoma Diagnosis and Treatment (14 papers). DL Longo collaborates with scholars based in United States, Malaysia and India. DL Longo's co-authors include W J Murphy, Scott K. Durum, ES Jaffe, F W Ruscetti, Sten Eirik W. Jacobsen, J R Keller, Kjetil Hestdal, Robert H. Wiltrout, William C. Kopp and ES Jaffe and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and The Journal of Experimental Medicine.

In The Last Decade

DL Longo

82 papers receiving 4.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
DL Longo United States 37 2.2k 1.6k 1.1k 988 645 83 4.8k
Birgitta Sander Sweden 37 1.4k 0.6× 1.3k 0.8× 1.5k 1.3× 1.0k 1.0× 1.1k 1.6× 141 4.4k
David Chantry United States 35 3.0k 1.4× 1.8k 1.1× 290 0.3× 1.1k 1.1× 289 0.4× 74 5.5k
Anna Cabrelle Italy 33 1.8k 0.8× 994 0.6× 423 0.4× 1.2k 1.2× 651 1.0× 60 3.7k
Laurence Boumsell France 48 3.4k 1.5× 886 0.6× 1.0k 0.9× 1.3k 1.4× 541 0.8× 152 6.8k
Itsuo Iwamoto Japan 51 4.4k 2.0× 1.1k 0.7× 568 0.5× 1.1k 1.2× 238 0.4× 167 7.7k
Daniel H.D. Gray Australia 43 3.7k 1.7× 1.5k 1.0× 346 0.3× 2.4k 2.4× 432 0.7× 120 7.2k
P. Bardos France 24 1.5k 0.7× 747 0.5× 521 0.5× 884 0.9× 554 0.9× 107 3.5k
Luis Llorente Mexico 35 2.3k 1.0× 643 0.4× 461 0.4× 626 0.6× 192 0.3× 154 4.4k
Katsuhiko Yamasaki Japan 15 2.1k 1.0× 1.3k 0.8× 275 0.2× 1.0k 1.0× 237 0.4× 19 3.7k
Dianne Grail Australia 25 2.7k 1.2× 1.6k 1.0× 436 0.4× 1.7k 1.8× 238 0.4× 30 5.5k

Countries citing papers authored by DL Longo

Since Specialization
Citations

This map shows the geographic impact of DL Longo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by DL Longo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites DL Longo more than expected).

Fields of papers citing papers by DL Longo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by DL Longo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by DL Longo. The network helps show where DL Longo may publish in the future.

Co-authorship network of co-authors of DL Longo

This figure shows the co-authorship network connecting the top 25 collaborators of DL Longo. A scholar is included among the top collaborators of DL Longo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with DL Longo. DL Longo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kenny, James J., et al.. (1995). Ig gamma 2b transgenes promote B cell development but alternate developmental pathways appear to function in different transgenic lines.. The Journal of Immunology. 154(11). 5694–5705. 15 indexed citations
2.
Steis, Ronald G. & DL Longo. (1994). Clinical Relevance of Recombinant Interferon-α 2a Antibodies in Patients with Hairy Cell Leukemia. Journal of Interferon Research. 14(4). 207–209. 9 indexed citations
3.
Taub, Dennis D., Galia Tsarfaty, Andrew R. Lloyd, et al.. (1994). Growth hormone promotes human T cell adhesion and migration to both human and murine matrix proteins in vitro and directly promotes xenogeneic engraftment.. Journal of Clinical Investigation. 94(1). 293–300. 82 indexed citations
4.
5.
Norihisa, Y, Daniel W. McVicar, Paulomi Ghosh, et al.. (1994). Increased proliferation, cytotoxicity, and gene expression after stimulation of human peripheral blood T lymphocytes through a surface ganglioside (GD3). The Journal of Immunology. 153(2). 910–910. 33 indexed citations
6.
Whang‐Peng, Jacqueline, Tor Knutsen, Elaine S. Jaffe, et al.. (1994). Cytogenetic study of two cases with lymphoma of mucosa-associated lymphoid tissue. Cancer Genetics and Cytogenetics. 77(1). 74–80. 28 indexed citations
7.
Murphy, W J, Timothy Back, Kevin C. Conlon, et al.. (1993). Antitumor effects of interleukin-7 and adoptive immunotherapy on human colon carcinoma xenografts.. Journal of Clinical Investigation. 92(4). 1918–1924. 38 indexed citations
8.
Murphy, W J, Scott K. Durum, & DL Longo. (1993). Differential effects of growth hormone and prolactin on murine T cell development and function.. The Journal of Experimental Medicine. 178(1). 231–236. 119 indexed citations
9.
Yano, Takahiro, et al.. (1993). Molecular analysis of the BCL-3 locus at chromosome 17q22 in B-cell neoplasms. Blood. 82(6). 1813–1819. 14 indexed citations
10.
Ochoa, Juan B., Brendan D. Curti, Andrew B. Peitzman, et al.. (1992). Increased Circulating Nitrogen Oxides After Human Tumor Immunotherapy: Correlation With Toxic Hemodynamic Changes. JNCI Journal of the National Cancer Institute. 84(11). 864–867. 97 indexed citations
11.
12.
Hestdal, Kjetil, Sten Eirik W. Jacobsen, FW Ruscetti, et al.. (1992). In vivo effect of interleukin-1 alpha on hematopoiesis: role of colony- stimulating factor receptor modulation. Blood. 80(10). 2486–2494. 24 indexed citations
13.
Murphy, W J, Scott K. Durum, & DL Longo. (1992). Human growth hormone promotes engraftment of murine or human T cells in severe combined immunodeficient mice.. Proceedings of the National Academy of Sciences. 89(10). 4481–4485. 78 indexed citations
14.
Sznol, Mario, J. W. Clark, John W. Smith, et al.. (1992). Pilot Study of Interleukin-2 and Lymphokine-Activated Killer Cells Combined With Immunomodulatory Doses of Chemotherapy and Sequenced With Interferon Alfa-2a in Patients With Metastatic Melanoma and Renal Cell Carcinoma. JNCI Journal of the National Cancer Institute. 84(12). 929–937. 26 indexed citations
15.
Conlon, Kevin C., William C. Kopp, John R. Ortaldo, et al.. (1992). Enhanced lymphokine production and lymphokine receptor expression in multiple antibody-stimulated human CD4+ peripheral blood lymphocytes. The Journal of Immunology. 149(10). 3278–3289. 11 indexed citations
16.
Hestdal, Kjetil, Sten Eirik W. Jacobsen, FW Ruscetti, et al.. (1992). In vivo effect of interleukin-1 alpha on hematopoiesis: role of colony- stimulating factor receptor modulation. Blood. 80(10). 2486–2494. 1 indexed citations
17.
Urba, Walter J., William C. Kopp, J. W. Clark, et al.. (1991). The in vivo immunomodulatory effects of recombinant interferon gamma plus recombinant tumor necrosis factor-alfa.. Journal of Clinical Oncology. 9(10). 1831–1839. 7 indexed citations
18.
Hestdal, Kjetil, F W Ruscetti, James N. Ihle, et al.. (1991). Characterization and regulation of RB6-8C5 antigen expression on murine bone marrow cells. The Journal of Immunology. 147(1). 22–28. 444 indexed citations
19.
Steis, Ronald G., DL Longo, Jeffrey W. Clark, et al.. (1990). Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor in Patients With Advanced Malignancy: A Phase Ib Trial. JNCI Journal of the National Cancer Institute. 82(8). 697–703. 34 indexed citations
20.
Glimcher, L H, et al.. (1981). Murine syngeneic mixed lymphocyte response. I. Target antigens are self Ia molecules. The Journal of Experimental Medicine. 154(5). 1652–1670. 119 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Birgitta Sander Breakdown of academic impact, for papers by David Chantry Breakdown of academic impact, for papers by Anna Cabrelle Breakdown of academic impact, for papers by Laurence Boumsell Breakdown of academic impact, for papers by Itsuo Iwamoto Breakdown of academic impact, for papers by Daniel H.D. Gray Breakdown of academic impact, for papers by P. Bardos Breakdown of academic impact, for papers by Luis Llorente Breakdown of academic impact, for papers by Katsuhiko Yamasaki Breakdown of academic impact, for papers by Dianne Grail
Rankless by CCL
2026